NO20044169L - Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme - Google Patents

Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme

Info

Publication number
NO20044169L
NO20044169L NO20044169A NO20044169A NO20044169L NO 20044169 L NO20044169 L NO 20044169L NO 20044169 A NO20044169 A NO 20044169A NO 20044169 A NO20044169 A NO 20044169A NO 20044169 L NO20044169 L NO 20044169L
Authority
NO
Norway
Prior art keywords
producing
methods
same
sex hormones
proteins capable
Prior art date
Application number
NO20044169A
Other languages
English (en)
Inventor
Shigeru Fujimoto
Yasuhiro Goda
Masanao Katagiri
Original Assignee
Japan Enviro Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Enviro Chemicals Ltd filed Critical Japan Enviro Chemicals Ltd
Publication of NO20044169L publication Critical patent/NO20044169L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20044169A 2002-03-01 2004-09-30 Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme NO20044169L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002055669 2002-03-01
PCT/JP2003/002311 WO2003074704A1 (fr) 2002-03-01 2003-02-28 Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation

Publications (1)

Publication Number Publication Date
NO20044169L true NO20044169L (no) 2004-11-16

Family

ID=27784617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044169A NO20044169L (no) 2002-03-01 2004-09-30 Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme

Country Status (5)

Country Link
US (1) US20060110771A1 (no)
EP (1) EP1486566A4 (no)
AU (1) AU2003211337A1 (no)
NO (1) NO20044169L (no)
WO (1) WO2003074704A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ724971A (en) 2010-02-24 2019-06-28 Immunogen Inc Folate receptor 1 antibodies and immunoconjugates and uses thereof
EP3318273B1 (en) 2011-04-01 2019-08-21 ImmunoGen, Inc. Methods for increasing efficacy of folr1 cancer therapy
RS60217B1 (sr) 2012-08-31 2020-06-30 Immunogen Inc Dijagnostički testovi i kompleti za detekciju folatnog receptora 1
RU2725825C2 (ru) 2013-08-30 2020-07-06 Иммьюноджен Инк. Антитела и методы анализа для обнаружения рецептора фолиевой кислоты 1
EP3349796A4 (en) 2015-09-17 2019-05-29 ImmunoGen, Inc. THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI913434A (fi) * 1990-07-16 1992-01-17 Technical Research Centre F Finland Rekombinanta fusionsproteiner vilka utsoendras.
US5342760A (en) * 1992-06-10 1994-08-30 Abbott Laboratories Determination of estradiol by competitive immunoassay
JP3525221B2 (ja) * 1993-02-17 2004-05-10 味の素株式会社 免疫抑制剤
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
IL111748A0 (en) * 1993-12-03 1995-01-24 Zeneca Ltd Proteins
WO1996036361A1 (en) * 1995-05-18 1996-11-21 The Regents Of The University Of Michigan Dna binding antibodies
US5977319A (en) * 1996-10-21 1999-11-02 Cambridge Antibody Technology Limited Specific binding members for estradiol; materials and methods
JPH10309198A (ja) * 1997-05-12 1998-11-24 Tosoh Corp 抗体、遺伝子及びキメラ抗体の製法
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
EP1258729A3 (en) * 2001-05-18 2004-01-02 Takeda Chemical Industries, Ltd. A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
WO2003101611A1 (fr) * 2002-05-31 2003-12-11 Japan Envirochemicals, Ltd. Materiau d'isolation destine a une substance perturbant les fonctions hormonales, technique de concentration et technique de nettoyage

Also Published As

Publication number Publication date
US20060110771A1 (en) 2006-05-25
EP1486566A1 (en) 2004-12-15
WO2003074704A1 (fr) 2003-09-12
AU2003211337A1 (en) 2003-09-16
EP1486566A4 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
NO20031776D0 (no) Null-boringskomplettering og produksjonssystem
IS7369A (is) Aðferð og tæki til örflögunýmyndunar
NO20051397D0 (no) Enkeltfase samlingsapparat og fremgangsmate
DK1628749T3 (da) Anordninger og fremgangsmåder til biomateriel produktion
NO20052014D0 (no) Prosess og system for behandling av bronner
DK2336147T3 (da) Beta-immunogen-peptid-bærerkonjugater og fremgangsmåder til fremstilling deraf
AU2003236303A1 (en) Organ connecting device and method for using the device
DK1271537T3 (da) Fremgangsmåde og indretning til simplificering af adgangen til metadata
AU2003237884A1 (en) Method and device for anastomoses
IS7045A (is) Tæki og aðferð til að framleiða háþrýstivetni
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
EP1492049A4 (en) CREATION OF FACIAL METADATA
NO20043839L (no) Havbunnsbasert intervensjonssystem, fremgangsmate for og komponeter i dette
IS7726A (is) Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
DK1551332T3 (da) Fladstrikket stent og fremgangsmåde til fremstilling deraf
GB2431061B (en) Synchronous follow-up apparatus and synchronous follow-up method
NO20055778D0 (no) Folgesystem og assosiert fremgangsmate
NO20051875D0 (no) Kjoleror og fremgangsmate for bruk av dette
ATE496940T1 (de) Ghrelin-analoga
DK1426784T3 (da) Indretning og fremgangsmåde til positionsbestemmelse
NO20052188D0 (no) System og fremgangsmate for fremstilling av polysulfid
FI20020314A0 (fi) Menetelmä kartongin valmistamiseksi sekä kartonkituote
NO20020860D0 (no) Betalingskort og tilhörende fremgangsmåte
NO20044169L (no) Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application